Health> Vol.5 No.11, November 2013

The potential biological mechanisms of obesity effects on depression: A systematic review of the literature and knowledge mining

DownloadDownload as PDF (Size:133KB)  HTML    PP. 1811-1818  

ABSTRACT

Depression and obesity (BMI ≥ 30) have been recognized as major public health issues worldwide. Although they have traditionally been compartmentalized as separate physical and emotional health conditions, evidence has suggested interactions and common pathways between them, implying that they probably shared common underlying biological mechanisms. By a systematic review of the literature and knowledge mining, we explore a potential biological mechanism of obesity effects on depression. Bioactivators in the body of obesity including adiponectin, leptin and its receptors, ghrelin, endocannabinoids and orexin receptors may contribute to depression by the hypothalamic pituitary adrenal axis, psycho-neuro-immunological system, neurovegetative system and brain areas control of mood and emotion such as hippocampus, cortex and amygdala.

Cite this paper

Gong, Y. , Wang, D. , Zhang, X. , Qu, Z. , Liu, P. and Zou, H. (2013) The potential biological mechanisms of obesity effects on depression: A systematic review of the literature and knowledge mining. Health, 5, 1811-1818. doi: 10.4236/health.2013.511244.

References

[1] Smith, M.M. and Minson, C.T. (2012) Obesity and adipokines: Effects on sympathetic overactivity. Journal of Physiology, 590, 1787-1801.
[2] Finkelstein, E.A., Trogdon, J.G. and Cohen, J.W. (2009) Annual medical spending attributable to obesity: Payer-and service-specific estimates. Health Affairs, 28, 822-831. http://dx.doi.org/10.1377/hlthaff.28.5.w822
[3] Dixon, J.B. (2009) The effect of obesity on health outcomes. Molecular and Cellular Endocrinology, 316, 104-108. http://dx.doi.org/10.1016/j.mce.2009.07.008
[4] Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 1595-1599. http://dx.doi.org/10.1161/01.ATV.20.6.1595
[5] Faith, M.S., Matz, P.E. and Jorge, M.A. (2002) Obesity-depression associations in the population. Journal of Psychosomatic Research, 53, 935-942.
http://dx.doi.org/10.1016/S0022-3999(02)00308-2
[6] Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y. and Matsubara, K. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochemical and Biophysical Research Communications, 221, 286-289. http://dx.doi.org/10.1006/bbrc.1996.0587
[7] Díez, J.J. and Iglesias, P. (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. European Journal of Endocrinology, 148, 293-300.
http://dx.doi.org/10.1530/eje.0.1480293
[8] Chen, J. (2006) Secretion of adiponectin by human placenta: Differential modulation of adiponectin and its receptors by cytokines. Diabetalogica, 49, 1292-1302.
http://dx.doi.org/10.1007/s00125-006-0194-7
[9] Renaldi, O., Pramono, B., Sinorita, H., Purnomo, L.B., Asdie, R.H. and Asdie, A.H. (2009) Hypoadiponectinemia: A risk factor for metabolic syndrome. Acta Medica Indonesiana, 134, 414-416.
[10] Ukkola, O. and Santaniemi, M. (2002) Adiponectin: A link between excess adiposity and associated comorbidities? Journal of Molecular Medicine, 80, 696-702.
http://dx.doi.org/10.1007/s00109-002-0378-7
[11] Leo, R., Di Lorenzo, G. and Tesauro, M. (2006) Decreased plasma adiponectin concentration in major depression. Neuroscience Letters, 407, 211-213.
http://dx.doi.org/10.1016/j.neulet.2006.08.043
[12] Yilmaz, Y. (2008) Psychopathology in the context of obesity: The adiponectin hypothesis. Medical Hypotheses, 70, 902-903.
http://dx.doi.org/10.1016/j.mehy.2007.08.019
[13] Nagata, T. and Yamada, H. (2006) Psycho-neuro-immunological aspects of eating disorders. International Congress Series, 1287, 279-284.
http://dx.doi.org/10.1016/j.ics.2005.11.097
[14] Narita, K., Murata, T., Takahashi, T., Kosaka, H., Omata, N. and Wada, Y. (2006) Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, 1159-1162.
http://dx.doi.org/10.1016/j.pnpbp.2006.03.030
[15] Weber-Hamann, B., Kratzsch, J. and Kopf, D. (2007) Resistin and a diponectin in major depression: The association with free cortisol and effects of antidepressant treatment. Journal of Psychiatric Research, 41, 344-350.
http://dx.doi.org/10.1016/j.jpsychires.2006.01.002
[16] Mamalakis, G., Kiriakakis, M. and Tsibinos, G. (2006) Depression and serum adiponectin and adipose omega-3 and omega-6 fatty acids in adolescents. Pharmacology Biochemistry and Behavior, 85, 474-479.
http://dx.doi.org/10.1016/j.pbb.2006.10.008
[17] Pan, A., Ye, X., Franco, O.H., Li, H., Yu, Z., Wang, J., Qi, Q., Gu, W., Pang, X., Liu, H. and Lin, X. (2008) The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese. PLoS ONE, 3, 1392.
http://dx.doi.org/10.1371/journal.pone.0001392
[18] Chen, Y.C., Lin, W.W., Chen, Y.J., Mao, W.C., Hung, Y.J. (2010) Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males. Mediators of Inflammation, Article ID: 573594.
http://dx.doi.org/10.1155/2010/573594
[19] You, T., Nicklas, B.J. and Ding, J. (2008) The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity. Journal of Gerontology, Series A, 63, 414-419.
http://dx.doi.org/10.1093/gerona/63.4.414
[20] Fernandez-Real, J.M., Lopez-Bermejo, A. and Casamitjana, R. (2003) Novel interactions of adiponectin with the endocrine system and inflammatory parameters. The Journal of Clinical Endocrinology & Metabolism, 88, 2714-2718. http://dx.doi.org/10.1210/jc.2002-021583
[21] Aldhahi, W. and Hamdy, O. (2003) Adipokines, inflamemation, and the endothelium in diabetes. Current Diabetes Reports, 3, 293-298.
http://dx.doi.org/10.1007/s11892-003-0020-2
[22] Tilg, H. and Wolf, A.M. (2005) Adiponectin:a key fatderived molecule regulating inflammation. Expert Opinion on Biological Therapy, 9, 245-251.
http://dx.doi.org/10.1517/14728222.9.2.245
[23] Fasshauer, M., Klein, J., Neumann, S., Eszlinger, M. and Paschke, R. (2002) Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications, 290, 1084-1089.
http://dx.doi.org/10.1006/bbrc.2001.6307
[24] Bruun, J.M., Lihn, A.S. and Verdich, C. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans. American Journal of Physiology, 285, 527-533.
[25] Fallo, F., Scarda, A. and Sonino, N. (2004) Effect of glucocorticoids on adiponectin: A study in healthy subjects and in Cushing’s syndrome. European Journal of Endocrinology, 150, 339-344.
http://dx.doi.org/10.1530/eje.0.1500339
[26] Chehab, F.F. (2000) Leptin as a regulator of adipose mass and reproduction. Trends in Pharmacological Sciences, 21, 309-314.
http://dx.doi.org/10.1016/S0165-6147(00)01514-5
[27] Farr, S.A., Banks, W.A. and Morley, J.E. (2006) Effects of leptin on memory processing. Peptides, 27, 1420-1425.
http://dx.doi.org/10.1016/j.peptides.2005.10.006
[28] Lu, X.Y., Kim, C.S., Frazer, A. and Zhang, W. (2006) Leptin: A potential novel antidepressant. Proceedings of the National Academy of Sciences of the USA, 103, 1593-1598. http://dx.doi.org/10.1073/pnas.0508901103
[29] Willner, P. (2005) Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology, 52, 90-110.
http://dx.doi.org/10.1159/000087097
[30] Katz, R.J. (1982) Animal model of depression: Pharmacological sensitivity of a hedonic deficit. Pharmacology Biochemistry and Behavior, 16, 965-968.
http://dx.doi.org/10.1016/0091-3057(82)90053-3
[31] Antonijevic, I.A., Murck, H., Frieboes, R.M., Horn, R., Brabant, G. and Steiger, A. (1998) Elevated nocturnal profiles of serum leptin in patients with depression. Journal of Psychiatric Research, 32, 403-410.
http://dx.doi.org/10.1016/S0022-3956(98)00032-6
[32] Rubin, R.T., Rhodes, M.E. and Czambel, R.K. (2002) Sexual diergism of baseline plasma leptin and leptin suppression by arginine vasopressin in major depressives and matched controls. Psychiatry Research, 113, 255-268.
http://dx.doi.org/10.1016/S0165-1781(02)00263-9
[33] Jow, G.M., Yang, T.T. and Chen, C.L. (2006) Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. Journal of Affective Disorders, 90, 21-27. http://dx.doi.org/10.1016/j.jad.2005.09.015
[34] Kraus, T., Haack, M., Schuld, A., Hinze-Selch, D. and Pollmacher, T. (2001) Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology, 73, 243-247.
http://dx.doi.org/10.1159/000054641
[35] Atmaca, M., Kuloglu, M., Tezcan, E., Ustundag, B., Gecici, O. and Firidin, B. (2002) Serum leptin and cholesterol values in suicide attempters. Neuropsychobiology, 45, 124-127. http://dx.doi.org/10.1159/000054950
[36] Westling, S., Ahren, B., Traskman-Bendz, L. and Westrin, A. (2004) Low CSF leptin in female suicide attempters with major depression. Journal of Affective Disorders, 81, 41-48. http://dx.doi.org/10.1016/j.jad.2003.07.002
[37] Simon, G.E., Von Korff, M., Saunders, K., et al. (2006) Association between obesity and psychiatric disorders in the US adult population. Archives of General Psychiatry, 63, 824-830. http://dx.doi.org/10.1001/archpsyc.63.7.824
[38] Munzberg, H. and Myers, M.G. (2005) Molecular and anatomical determinants of central leptin resistance. Nature Neuroscience, 8, 566-570.
http://dx.doi.org/10.1038/nn1454
[39] Vaishnav, K. and Eric, J.N. (2010) Linking molecules to mood: New insight into the biology of depression. American Journal of Psychiatry, 167, 1305-1320.
http://dx.doi.org/10.1176/appi.ajp.2009.10030434
[40] Lu, X.-Y. (2007) The leptin hypothesis of depression: A potential link between mood disorders and obesity? Current Opinion in Pharmacology, 7, 648-652.
http://dx.doi.org/10.1016/j.coph.2007.10.010
[41] Korbonits, M., Goldstone, A.P., Gueorguiev, M. and Grossman, A.B. (2004) Ghrelin—A hormone with multiple functions. Frontiers in Neuroendocrinology, 25, 27-68.
http://dx.doi.org/10.1016/j.yfrne.2004.03.002
[42] Kojima, M. and Kangawa, K. (2005) Ghrelin: Structure and function. Physiological Reviews, 85, 495-522.
http://dx.doi.org/10.1152/physrev.00012.2004
[43] Otto, B., Cuntz, U. and Fruehauf, E. (2001) Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. European Journal of Endocrinology, 145, 669-673.
[44] Cummings, D.E., Weigle, D.S. and Frayo, R.S. (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine, 346, 1623-1630.
http://dx.doi.org/10.1056/NEJMoa012908
[45] Leidy, H., Dougherty, K.A., Frye, B.R., Duke, K.M. and Williams, N.I. (2007) Twenty-four-hour ghrelin is elevated after calorie restriction and exercise training in non-obese women. Obesity, 15, 446-455.
http://dx.doi.org/10.1038/oby.2007.542
[46] Lutter, M., Sakata, I. and Osborne-Lawrence, S. (2008) The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nature Neuroscience, 11, 752-753. http://dx.doi.org/10.1038/nn.2139
[47] Asakawa, A., Inui, A. and Kaga, T. (2001) A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology, 74, 143-147.
http://dx.doi.org/10.1159/000054680
[48] Kristenssson, E., Sundqvist, M. and Astin, M. (2006) Acute psychological stress raises plasma ghrelin in the rat. Regulatory Peptides, 134, 114-117.
http://dx.doi.org/10.1016/j.regpep.2006.02.003
[49] Nestler, E.J., Barrot, M., Dileone, R.J., et al. (2002) Neurobiology of depression. Neuron, 34, 13-25.
http://dx.doi.org/10.1016/S0896-6273(02)00653-0
[50] Zigman, J.M., Jones, J.E., Lee, C.E., Saper, C.B. and Elmquist, J.K. (2006) Expression of ghrelin receptor mRNA in the rat and the mouse brain. Journal of Comparative Neurology, 494, 528-548.
http://dx.doi.org/10.1002/cne.20823
[51] Guan, X.M., Yu, H. and Palyha, O.C. (1997) Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Molecular Brain Research, 48, 23-29.
http://dx.doi.org/10.1016/S0169-328X(97)00071-5
[52] Diano, S., Farr, S.A., Benoit, S.C., et al. (2006) Ghrelin controls hippocampal spine synapse density and memory performance. Nature Neuroscience, 9, 381-388.
http://dx.doi.org/10.1038/nn1656
[53] Johansson, I., Destefanis, S. and Aberg, N.D. (2008) Proliferative and protective effects of growth hormone secretagogues on adult rat hippocampal progenitor cells. Endocrinology, 149, 2191-2199.
http://dx.doi.org/10.1210/en.2007-0733
[54] Moon, M., Kim, S., Hwang, L. and Park, S. (2009) Ghrelin regulates hippocampal neurogenesis in adult mice. Endocrine Journal, 56, 525-531.
http://dx.doi.org/10.1507/endocrj.K09E-089
[55] Cota, D., Marsicano, G., Lutz, B., Vicennati, V., Stalla, G.K., Pasquali, R. and Pagotto, U. (2003) Endogenous cannabinoid system as a modulator of food intake. International Journal of Obesity and Related Metabolic Disorders, 27, 289-301.
http://dx.doi.org/10.1038/sj.ijo.0802250
[56] Di Marzo, V. and Matias, I. (2005) Endocannabinoid control of food intake and energy balance. Nature Neuroscience, 8, 585-589. http://dx.doi.org/10.1038/nn1457
[57] Gorzalka, B.B., Hill, M.N. and Hillard, C.J. (2008) Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders. Neuroscience & Biobehavioral Reviews, 32, 1152-1160.
http://dx.doi.org/10.1016/j.neubiorev.2008.03.004
[58] Steiner, M.A. and Wotjak, C.T. (2008) Role of the endocannabinoid system in regulation of the hypothalamicpituitaryadrenocortical axis. Progress in Brain Research, 170, 397-432.
http://dx.doi.org/10.1016/S0079-6123(08)00433-0
[59] Matthew, N.H., Gregory, E.M., Erica, J.C., Boris, B.G. and Cecilia, J.H. (2009) Circulating endocannabinoids and n-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology, 34, 1257-1262.
http://dx.doi.org/10.1016/j.psyneuen.2009.03.013
[60] Hill, M.N. and Gorzalka, B.B. (2005) Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression? Behavioural Pharmacology, 16, 333-352.
http://dx.doi.org/10.1097/00008877-200509000-00006
[61] Randall, M.D. (2007) Endocannabinoids and the haematological system. British Journal of Pharmacology, 152, 671-675. http://dx.doi.org/10.1038/sj.bjp.0707420
[62] Matias, I., Bisogno, T. and Di Marzo, V. (2006) Endogenous cannabinoids in the brain and peripheral tissues: Regulation of their levels and control of food intake. International Journal of Obesity, 30, 7-12.
http://dx.doi.org/10.1038/sj.ijo.0803271
[63] Hill, M.N., Miller, G.E. and Ho, W.S. (2008) Serum endocannabinoid content is altered in females with depresssive disorders: A preliminary report. Pharmacopsychiatry, 41, 48-53. http://dx.doi.org/10.1055/s-2007-993211
[64] Matias, I., Gonthier, M.P. and Petrosino, S. (2007) Role and regulation of acylethanolamides in energy balance: Focus on adipocytes and beta-cells. British Journal of Pharmacology, 152, 676-690.
http://dx.doi.org/10.1038/sj.bjp.0707424
[65] Christensen, R., Kristensen, P.K. and Bartels, E.M. (2007) Efficacy and safety of the weight-loss drug rimonabant: A meta-analysis of randomised trials. Lancet, 370, 1706-1713. http://dx.doi.org/10.1016/S0140-6736(07)61721-8
[66] De Lecea, L., Kilduff, T.S. and Peyron, C. (1998) The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. PNAS, 95, 322-327.
http://dx.doi.org/10.1073/pnas.95.1.322
[67] Sakurai, T.A.A., Ishii, M. and Matsuzaki, I. (1998) Orexins and orexin receptors: A family of hypothalamic neuropeptides and G-proteincoupled receptors that regulate feeding behaviour. Cell, 92, 573-585.
http://dx.doi.org/10.1016/S0092-8674(00)80949-6
[68] Ida, T.N.K., Katayama, T. and Murakami, N. (1999) Effect of lateral cerebroventricular injection of the appetitestimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Research, 821, 526-529.
http://dx.doi.org/10.1016/S0006-8993(99)01131-2
[69] Samson, W.K., Gosnell, B. and Chang, J.K. (1999) Cardiovascular regulatory actions of the hypocretins in brain. Brain Research, 831, 248-253.
http://dx.doi.org/10.1016/S0006-8993(99)01457-2
[70] Peyron, C., Faraco, J. and Rogers, W. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature Medicine, 6, 991-997.
http://dx.doi.org/10.1038/79690
[71] Digby, J.E., Chen, J. and Tang, J.Y. (2006) Orexin receptor expression in human adipose tissue: Effects of orexin-A and orexin-B. Journal of Endocrinology, 191, 129-136.
http://dx.doi.org/10.1677/joe.1.06886
[72] Randeva, H.S., Karteris, E. and Grammatopoulos, D. (2001) Expression of orexin-A and functional orexin type 2 receptors in the humanadult adrenals: Implications for adrenal function and energy homeostasis. The Journal of Clinical Endocrinology & Metabolism, 86, 4808-4813.
http://dx.doi.org/10.1210/jc.86.10.4808
[73] Karteris, E., Machado, R.J. and Chen, J. (2005) Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex. American Journal of Physiology, 288, 1089-1100.
[74] Johren, O., Neidert, S.J. and Kummer, M. (2001) Preproorexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology, 142, 3324-3331.
http://dx.doi.org/10.1210/en.142.8.3324
[75] Marchant, E.G. and Mistlberger, R.E. (1997) Anticipation and entrainment to feeding time in intact and SCN-ablated C57BL/6j mice. Brain Research, 765, 273-282.
http://dx.doi.org/10.1016/S0006-8993(97)00571-4
[76] Yamanaka, A., Beuckmann, C.T. and Willie, J.T. (2003) Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron, 38, 701-713.
http://dx.doi.org/10.1016/S0896-6273(03)00331-3
[77] Inoue, K., Zorrilla, E.P. and Tabarin, A. (2004) Reduction of anxiety after restricted feeding in the rat: Implication for eating disorders. Biological Psychiatry, 55, 1075-1081. http://dx.doi.org/10.1016/j.biopsych.2004.01.026
[78] Holtkamp, K., Herpertz-Dahlmann, B., Mika, C., et al. (2003) Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa. The Journal of Clinical Endocrinology & Metabolism, 88, 5169-5174.
http://dx.doi.org/10.1210/jc.2003-030569
[79] Brundin, L., Bjorkqvist, M. and Petersen, A. (2007) Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. European Neuropsychopharmacology, 17, 573-579.
http://dx.doi.org/10.1016/j.euroneuro.2007.01.005
[80] Harris, G.C., Wimmer, M. and Aston-Jones, G. (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature, 437, 556-559.
http://dx.doi.org/10.1038/nature04071
[81] Harris, G.C. and Aston-Jones, G. (2006) Arousal and reward: A dichotomy in orexin function. Trends in Neurosciences, 29, 571-577.
http://dx.doi.org/10.1016/j.tins.2006.08.002

  
comments powered by Disqus

Copyright © 2014 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.